[go: up one dir, main page]

MA41623A - Composition lyophilisée de composé de benzimidazole - Google Patents

Composition lyophilisée de composé de benzimidazole

Info

Publication number
MA41623A
MA41623A MA041623A MA41623A MA41623A MA 41623 A MA41623 A MA 41623A MA 041623 A MA041623 A MA 041623A MA 41623 A MA41623 A MA 41623A MA 41623 A MA41623 A MA 41623A
Authority
MA
Morocco
Prior art keywords
lyophilized composition
benzimidazole compound
benzimidazole
compound
lyophilized
Prior art date
Application number
MA041623A
Other languages
English (en)
Inventor
Ali Türkyilmaz
Gülay Yelken
Original Assignee
Verano Ilac Sanayi Ve Ticaret A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verano Ilac Sanayi Ve Ticaret A S filed Critical Verano Ilac Sanayi Ve Ticaret A S
Publication of MA41623A publication Critical patent/MA41623A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA041623A 2015-11-26 2016-11-24 Composition lyophilisée de composé de benzimidazole MA41623A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201515019 2015-11-26

Publications (1)

Publication Number Publication Date
MA41623A true MA41623A (fr) 2018-01-09

Family

ID=57421667

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041623A MA41623A (fr) 2015-11-26 2016-11-24 Composition lyophilisée de composé de benzimidazole

Country Status (3)

Country Link
EP (1) EP3173070A1 (fr)
MA (1) MA41623A (fr)
WO (1) WO2017089512A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020325705A1 (en) * 2019-08-05 2022-03-03 Polyplus Transfection Compositions for transfecting a nucleic acid molecule into a cell comprising heterocyclic compounds grafted to a cationic polymer, and their applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915986A (en) 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
US4076828A (en) 1977-02-17 1978-02-28 E. R. Squibb & Sons, Inc. Method of treating helminthiasis by parenteral administration of sulfoxide derivatives of benzimidazoles
EP0705101B1 (fr) 1993-05-26 2001-12-19 Commonwealth Scientific And Industrial Research Organisation Compositions anti-parasitaires
US20070014875A1 (en) * 2003-11-05 2007-01-18 Bajaj Mannalal R Novel drug delivery system for proton pump inhibitors and process thereof
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby

Also Published As

Publication number Publication date
EP3173070A1 (fr) 2017-05-31
WO2017089512A1 (fr) 2017-06-01

Similar Documents

Publication Publication Date Title
EP3366684A4 (fr) Composé hétérocyclique
PT3355990T (pt) Compostos semifluorados e as suas composições
EP3360864A4 (fr) Composé pyrimidine
DK3298027T3 (da) Anthelmintiske depsipeptidforbindelser
DK3286183T3 (da) Isoxazolylsubstituerede benzimidazoler
EP3339331A4 (fr) Composition
EP3398996A4 (fr) Composition
EP3327019A4 (fr) Composé hétérocyclique
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
EP3354638A4 (fr) Composé de phtalonitrile
DK3370949T3 (da) Sammensætning af tætningsmiddel
EP3366679A4 (fr) Composé hétérocyclique
PT3261437T (pt) Compostos e composições fungicidas
EP3299355A4 (fr) Composé de phtalonitrile
EP3372604A4 (fr) Composé hétérocyclique condensé
EP3372588A4 (fr) Composé de pyrimidine
EP3533799A4 (fr) Composé
EP3438103A4 (fr) Composé de griséofulvine
EP3395887C0 (fr) Composition de caoutchouc fluoré
DE102015105763A8 (de) Korrosionsschutzzusammensetzung
EP3366674A4 (fr) Composé de pyridine
DK3322295T3 (da) Sammensætning
IL254502B (en) Solid forms of menaquinols
MA43275A (fr) Composé de pyranodipyridine